- idUS
- Listar por autor
Listar por autor "Ramalingam, Suresh S."
Mostrando ítems 1-2 de 2
-
Artículo
First-Line Nivolumab Plus Ipilimumab in Advanced NSCLC: 4-Year Outcomes From the Randomized, Open-Label, Phase 3 CheckMate 227 Part 1 Trial
Paz Ares, Luis; Ramalingam, Suresh S.; Ciuleanu, Tudor Eliade; Lee, Jong Seok; Urban, Laszlo; Bernabé-Caro, Reyes; Reck, Martin (ELSEVIER SCIENCE INC, 2022)Introduction: In CheckMate 227, nivolumab plus ipilimu mab prolonged overall survival (OS) versus chemotherapy in patients ...
-
Artículo
Veliparib in Combination With Platinum-Based Chemotherapy for First-Line Treatment of Advanced Squamous Cell Lung Cancer: A Randomized, Multicenter Phase III Study
Ramalingam, Suresh S.; Novello, Silvia; Guclu, Salih Zeki; Bentsion, Dmitry; Zvirbule, Zanete; Szilasi, Maria; Bernabé-Caro, Reyes (American Society Clinical Oncology, 2021)PURPOSE Squamous non–small-cell lung cancer (sqNSCLC) is genetically complex with evidence of DNA damage. This phase III ...